Mangalam Drugs and Organics Ltd.

About

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. Additionally, it offers active pharmaceutical ingredients; and products covering various therapeutic areas comprising anti-malaria, anti-retroviral, anti-hypertensive, anti-inflammatory, anti-convulsant, anti-viral, anti-rheumatic arthritis agents, and anti-bacterial, as well as develops product for anti-hypertensive indications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap47 Cr

P/E—

Div Yield0.00 %

Book Value₹65.10

52w High₹86.00

52w Low₹22.70

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	57.12	67.29	58.38	49.54	57.21	72.78	88.71	79.94	76.53	102.24	97.34	81.56	87.46
Expenses	56.22	72.65	59.96	52.37	61.86	62.88	79.94	71.25	68.34	90.54	90.36	79.37	90.94
Operating Profit	0.90	-5.36	-1.58	-2.83	-4.65	9.90	8.77	8.69	8.19	11.70	6.98	2.19	-3.48
OPM %	1.58	-7.97	-2.71	-5.71	-8.13	13.60	9.89	10.87	10.70	11.44	7.17	2.69	-3.98
Other Income	0.11	0.09	0.22	0.03	0.14	0.47	0.13	0.14	0.02	0.05	0.00	0.03	0.02
Depreciation	3.99	4.56	4.37	4.53	4.38	4.61	3.93	3.97	3.87	3.86	3.62	3.73	3.42
Interest	3.68	3.08	4.05	5.03	4.04	4.03	3.49	3.67	3.75	3.95	3.31	3.24	3.41
Profit before tax	-6.66	-12.91	-9.78	-12.36	-12.93	1.73	1.48	1.19	0.59	3.94	0.05	-4.75	-10.29
Tax %	13.36	1.16	0.00	-41.42	6.19	90.75	5.41	-125.21	-355.93	9.90	-920.00	-25.05	-7.29
Net Profit	-7.55	-13.06	-9.78	-7.25	-13.73	0.15	1.40	2.69	2.68	3.55	0.50	-3.56	-9.54
EPS in Rs	-4.77	-8.25	-6.18	-4.58	-8.67	0.09	0.88	1.70	1.69	2.24	0.32	-2.25	-6.03

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	232.00	318.00	369.00	372.00	451.00	380.00	282.00	228.00	269.00	299.00	295.00	221.00
Expenses	247.00	282.00	351.00	347.00	402.00	327.00	259.00	218.00	222.00	252.00	257.00	200.00
Operating Profit	-15.00	36.00	17.00	26.00	49.00	53.00	24.00	10.00	47.00	47.00	38.00	20.00
OPM %	-6.00	11.00	4.70	7.00	11.00	14.00	8.00	4.30	17.00	16.00	13.00	9.00
Other Income	1.00	0.00	0.00	0.00	0.00	5.00	1.00	0.00	1.00	0.00	0.00	0.00
Interest	16.00	15.00	14.00	13.00	11.00	9.00	10.00	9.00	12.00	10.00	9.00	10.00
Depreciation	18.00	16.00	15.00	11.00	10.00	9.00	8.00	7.00	7.00	5.00	4.00	4.00
Profit before tax	-48.00	5.00	-11.00	2.00	28.00	40.00	6.00	-6.00	29.00	31.00	24.00	6.00
Tax %	-9.00	-39.00	-18.00	43.00	29.00	29.00	-32.00	40.00	32.00	29.00	33.00	-2.00
Net Profit	-44.00	7.00	-9.00	1.00	20.00	28.00	8.00	-8.00	20.00	22.00	16.00	6.00
EPS in Rs	-27.68	4.37	-5.72	0.80	12.42	17.67	5.21	-5.07	12.57	14.08	11.15	4.66
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	14.00	13.00
Reserves	87.00	133.00	127.00	136.00	135.00	115.00	88.00	80.00	88.00	70.00	47.00	16.00
Borrowings	105.00	96.00	107.00	89.00	88.00	70.00	52.00	65.00	69.00	66.00	60.00	78.00
Other Liabilities	99.00	114.00	108.00	117.00	90.00	64.00	75.00	50.00	54.00	38.00	38.00	63.00
Total Liabilities	308.00	359.00	357.00	358.00	328.00	264.00	231.00	211.00	227.00	190.00	160.00	170.00
Fixed Assets	152.00	156.00	147.00	142.00	135.00	118.00	101.00	103.00	102.00	93.00	54.00	53.00
CWIP	0.00	3.00	8.00	9.00	6.00	6.00	1.00	0.00	0.00	0.00	5.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.00	0.00	0.00
Other Assets	156.00	201.00	202.00	206.00	188.00	140.00	128.00	107.00	125.00	95.00	100.00	117.00
Total Assets	308.00	359.00	357.00	358.00	328.00	264.00	231.00	211.00	227.00	190.00	160.00	170.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	4.00	43.00	12.00	38.00	26.00	28.00	31.00	22.00	25.00	43.00	22.00	14.00
Cash from Investing Activity	-12.00	-19.00	-18.00	-22.00	-27.00	-31.00	-7.00	-9.00	-16.00	-39.00	-11.00	-4.00
Cash from Financing Activity	6.00	-22.00	6.00	-17.00	3.00	3.00	-23.00	-11.00	-9.00	-3.00	-11.00	-10.00
Net Cash Flow	-2.00	2.00	0.00	-1.00	1.00	-1.00	0.00	1.00	0.00	0.00	0.00	1.00
Free Cash Flow	-8.00	23.00	-6.00	16.00	-2.00	-4.00	24.00	12.00	9.00	3.00	11.00	10.00
CFO/OP %	-30.00	119.00	71.00	148.00	70.00	69.00	129.00	223.00	66.00	107.00	68.00	69.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	63.00	45.00	28.00	46.00	38.00	52.00	52.00	28.00	61.00	45.00	37.00	73.00
Inventory Days	239.00	303.00	185.00	200.00	139.00	85.00	121.00	175.00	132.00	69.00	85.00	134.00
Days Payable	160.00	199.00	124.00	139.00	65.00	63.00	106.00	77.00	82.00	38.00	37.00	128.00
Cash Conversion Cycle	142.00	148.00	88.00	107.00	112.00	74.00	67.00	126.00	111.00	75.00	85.00	79.00
Working Capital Days	-54.00	13.00	18.00	38.00	43.00	23.00	10.00	21.00	31.00	19.00	32.00	26.00
ROCE %	-14.00	8.00	1.00	6.00	18.00	27.00	11.00	2.00	25.00	31.00	29.00	16.00

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	35.65	35.65	35.64	50.30	50.30	50.30	50.30	50.30	50.31	50.31	50.31	50.31
FIIs	0.11	0.32	0.13	0.11	0.53	0.47	0.11	0.11	0.21	0.26	0.10	0.10
Public	64.24	64.03	64.22	49.57	49.16	49.23	49.58	49.58	49.47	49.42	49.59	49.59
No. of Shareholders	24,465	25,140	21,227	19,881	19,728	19,697	19,679	19,508	19,312	19,173	18,610	17,978

Corporate Actions

15 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Other	17 Sep 2018	—	—	—	Annual General Meeting
Dividend	21 Dec 2017	22 Dec 2017	—	0.50
Other	18 Sep 2017	—	—	—	Annual General Meeting
Other	22 Sep 2016	—	—	—	Annual General Meeting (Book Closure Dates Revised)
Other	26 Aug 2015	—	—	—	Annual General Meeting
Other	18 Sep 2014	—	—	—	Annual General Meeting
Other	17 Sep 2013	—	—	—	Annual General Meeting
Other	17 Sep 2012	—	—	—	Annual General Meeting
Other	20 Sep 2011	—	—	—	Annual General Meeting
Other	21 Sep 2010	—	—	—	Annual General Meeting
Other	17 Sep 2009	—	—	—	Annual General Meeting
Other	18 Sep 2008	—	—	—	Annual General Meeting
Other	18 Sep 2007	—	—	—	Agm
Dividend	19 Sep 2006	—	—	0.20
Dividend	30 Aug 2005	—	—	0.20

Announcements

5 filings

Announcement under Regulation 30 (LODR)-Newspaper Publication
01 Sep 2026 1 Sep - Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September, 2026 and information on E-voting.
Intimation Of 53Rd Annual General Meeting To Be Held On Wednesday, September 23Rd, 2026.
31 Aug 2026 31 Aug - 53rd AGM on September 23, 2026; annual report issued, auditor appointments and related-party approvals proposed.
Reg. 34 (1) Annual Report.
31 Aug 2026 31 Aug - 53rd AGM on September 23, 2026; annual report issued, auditor appointments and related-party approvals proposed.
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
17 Aug 2026 17 Aug - Company defaulted on Bank of Maharashtra loan ₹951.19 lakh and Bank of Baroda loan ₹606.08 lakh since Oct 2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Aug 2026 13 Aug - Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026